drugset
drugset / Trial / NCT02974374

Single Dose of PF-06835919 Escalation Study in Healthy Adult Subjects

NCT02974374 ↗

Phase 1 Completed 16 enrolled Pfizer
RandomizedDouble-blindTreatment

Summary

The purpose of this study is to assess the safety, tolerability, and pharmacokinetics of a single dose of PF-06835919 in healthy adult subjects.

Timeline

Start
2016-10
Primary completion
2017-01
Completion
2017-01

Drugs

EvaluationDrugModalityDoseRoute
Subject PF-06835919 Small molecule — Oral

Indications

NAFLD1